Brief: Werewolf Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results

Werewolf Therapeutics

23/03/2023 11:28

March 23 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * UPDATED CASH RUNWAY GUIDANCE TO FUND CASH FLOW
REQUIREMENTS
THROUGH AT LEAST 4Q 2024
    * QTRLY LOSS PER SHARE $0.39
    * COLLABORATION REVENUE WAS $7.3 MILLION FOR Q4 OF 2022,
COMPARED
TO ZERO FOR SAME PERIOD IN 2021
    * Q4 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4pdQL7 
Further company coverage:  HOWL.O 

 ((Reuters.Briefs@thomsonreuters.com;))